Overseas Investment News- China Business Network

Home > Overseas Investment News

Overseas Investment News

2021-07-26Sogou to Report Second Quarter 2021 Financial Results on August 9, 2021
2021-07-26Sohu.com to Report Second Quarter 2021 Financial Results on August 9, 2021
2021-07-23CGTN: CPC sets example for global development
2021-07-23GWM POER Lure International Championship Closes, Creating All-scenario Life
2021-07-22Nisun International Announces Strategic Collaboration with Retail Chain Giant Beijing Digital Telecom to Jointly Develop Supply Chain Services in Retail Industry
2021-07-22130th Canton Fair to be held both online and offline
2021-07-21Founder and leader of East Rock receives the Annual Outstanding Entrepreneur title at the 12th annual China-US Business Summit
2021-07-21Globaltality Holdings and HuaCan DreamWorks Sign Agreement to Expand Access to Coworking Spaces and Services across Greater China
2021-07-21More than 60 foreign-funded financial institutions settle in Beijing
2021-07-20The 2nd Qingdao Multinationals Summit builds new cooperation platform online and offline
2021-07-20Dogness (International) Corporation Closes $3.96 Million Offering
2021-07-19YishengBio Announces PIKA recombinant COVID-19 vaccine received Phase I clinical trial IND clearance from the UAE
2021-07-19LexinFintech Wins Global Finance Award for Outstanding Financial Innovator
2021-07-19TAL Education Group to Announce First Quarter of Fiscal Year 2022 Financial Results on August 5, 2021
2021-07-16Energy 1 Corp. announces change to board composition - Liu Yicheng, Cao Yilin and Zhang Jinyuan has officially joined the board
2021-07-16TD Holdings, Inc. Announces Entry into Non-Binding Letter of Intent for the Acquisition of Two Companies to Step into Unmanned Logistics and New Energy Vehicle Industry
2021-07-16Innovent Announces the First Patient Dosed in the Phase 1 Study of IBI319 (Anti-PD-1/CD137 Bispecific Antibody) in Patients with Advanced Malignant Tumors
2021-07-15Meten EdtechX Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
2021-07-15Ascentage Pharma and Innovent Biologics Reach Multifaceted Strategic Agreement Totaling US$245 Million Including Commercialization of Olverembatinib (HQP1351) in China, Joint Clinical Development of Lisaftoclax (APG-2575) and Equity Investment
2021-07-14Antengene Submits New Drug Application for Selinexor in Taiwan for the Treatment of Three Indications in Hematologic Malignancies

First　Previous　76 77 78 79 80　Next　Last　Total 3995 20/Page Page 77 of 200 Go To: